ReP USP - Resultado da busca

Artigo de periodico
Multivalent vaccine candidate from conserved immunogenic peptides in entry or exit proteins of Orthopoxvirus genus (2025)
Araújo, Leonardo Pereira de; Silva, Evandro Neves; Alencar, Severino Matias de ; Corsetti, Patrícia Paiva; Almeida, Leonardo Augusto de
Source: Scientific Reports. Unidade: ESALQ
Subjects: IMUNOGENICIDADE DA VACINA, PEPTÍDEOS, POXVIRIDAE, PROTEÍNAS, VACINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAÚJO, Leonardo Pereira de et al. Multivalent vaccine candidate from conserved immunogenic peptides in entry or exit proteins of Orthopoxvirus genus. Scientific Reports, v. 15, p. 1-13, 2025Tradução . . Disponível em: https://doi.org/10.1038/s41598-025-96755-4. Acesso em: 08 fev. 2026.
APA
Araújo, L. P. de, Silva, E. N., Alencar, S. M. de, Corsetti, P. P., & Almeida, L. A. de. (2025). Multivalent vaccine candidate from conserved immunogenic peptides in entry or exit proteins of Orthopoxvirus genus. Scientific Reports, 15, 1-13. doi:10.1038/s41598-025-96755-4
NLM
Araújo LP de, Silva EN, Alencar SM de, Corsetti PP, Almeida LA de. Multivalent vaccine candidate from conserved immunogenic peptides in entry or exit proteins of Orthopoxvirus genus [Internet]. Scientific Reports. 2025 ; 15 1-13.[citado 2026 fev. 08 ] Available from: https://doi.org/10.1038/s41598-025-96755-4
Vancouver
Araújo LP de, Silva EN, Alencar SM de, Corsetti PP, Almeida LA de. Multivalent vaccine candidate from conserved immunogenic peptides in entry or exit proteins of Orthopoxvirus genus [Internet]. Scientific Reports. 2025 ; 15 1-13.[citado 2026 fev. 08 ] Available from: https://doi.org/10.1038/s41598-025-96755-4
Artigo de periodico
Safety and immunogenicity of Ad26.COV2.S in adolescents: phase 2 randomized clinical trial (2025)
Tica, Jelena; Rezelj, Veronica V.; Baron, Benoit; Zaidman, Javier; Fairlie, Lee; Scheper, Gert; Struyf, Frank; Douoguih, Macaya; Le Gars, Mathieu; Mussi, Marisa Márcia
Source: Human Vaccines & Immunotherapeutics. Unidade: FMRP
Subjects: VACINAS, ADOLESCENTES, IMUNOGENICIDADE DA VACINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TICA, Jelena et al. Safety and immunogenicity of Ad26.COV2.S in adolescents: phase 2 randomized clinical trial. Human Vaccines & Immunotherapeutics, v. 21, n. 1, p. 1-12, 2025Tradução . . Disponível em: https://doi.org/10.1080/21645515.2025.2450120. Acesso em: 08 fev. 2026.
APA
Tica, J., Rezelj, V. V., Baron, B., Zaidman, J., Fairlie, L., Scheper, G., et al. (2025). Safety and immunogenicity of Ad26.COV2.S in adolescents: phase 2 randomized clinical trial. Human Vaccines & Immunotherapeutics, 21( 1), 1-12. doi:10.1080/21645515.2025.2450120
NLM
Tica J, Rezelj VV, Baron B, Zaidman J, Fairlie L, Scheper G, Struyf F, Douoguih M, Le Gars M, Mussi MM. Safety and immunogenicity of Ad26.COV2.S in adolescents: phase 2 randomized clinical trial [Internet]. Human Vaccines & Immunotherapeutics. 2025 ; 21( 1): 1-12.[citado 2026 fev. 08 ] Available from: https://doi.org/10.1080/21645515.2025.2450120
Vancouver
Tica J, Rezelj VV, Baron B, Zaidman J, Fairlie L, Scheper G, Struyf F, Douoguih M, Le Gars M, Mussi MM. Safety and immunogenicity of Ad26.COV2.S in adolescents: phase 2 randomized clinical trial [Internet]. Human Vaccines & Immunotherapeutics. 2025 ; 21( 1): 1-12.[citado 2026 fev. 08 ] Available from: https://doi.org/10.1080/21645515.2025.2450120
Artigo de periodico
Production and immune response against pandemic influenza candidate vaccines as preparedness against the circulating H5N1 influenza viruses (2025)
Ho, Paulo Lee ; Medina-Armenteros, Yordanka ; Dati, Lívia Mendonça Munhoz ; Cajado-Carvalho, Daniela ; Silva, Christian Savio ; Campos, Pollyanna Fernandes ; Abreu, Patrícia Antonia Estima ; Castro, Júlia Tavares de ; Tonolli, Paulo Newton ; Fujimori, Mahyumi ; Rosa, Rhubia Silveira Martins ; Palameta, Soledad ; Miller, Michael Edward ; Sakiara, Vitor Anselmo ; Valadares, Fernanda de Lima ; Lauretti-Ferreira, Fabiana ; Holanda, Bianca Pereira Carvalho ; Macedo, Douglas Gonçalves de; Comone, Priscila; Fogaça, Natully de Souza Suffert; Bimbo, Alexandre; Moraes, Felipe Catanzaro De; Andrade, Stephane Tereza Queiroz de; Arns, Clarice Weis ; Kallas, Esper Georges ; Akamatsu, Milena Apetito ; Oliveira, Ricardo das Neves ; Ferreira, Helena Lage ; Durigon, Edison Luiz
Source: Vaccines. Unidades: FZEA, ICB
Subjects: MICROBIOLOGIA, MODELOS ANIMAIS DE DOENÇAS, INFLUENZA, IMUNOGENICIDADE DA VACINA, VACINAS VIRAIS, ADJUVANTES IMUNOLÓGICOS, HIDROCARBONETOS, ANTÍGENOS DE VÍRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HO, Paulo Lee et al. Production and immune response against pandemic influenza candidate vaccines as preparedness against the circulating H5N1 influenza viruses. Vaccines, v. 13, n. 6, p. 21 , 2025Tradução . . Disponível em: https://doi.org/10.3390/vaccines13060620. Acesso em: 08 fev. 2026.
APA
Ho, P. L., Medina-Armenteros, Y., Dati, L. M. M., Cajado-Carvalho, D., Silva, C. S., Campos, P. F., et al. (2025). Production and immune response against pandemic influenza candidate vaccines as preparedness against the circulating H5N1 influenza viruses. Vaccines, 13( 6), 21 . doi:10.3390/vaccines13060620
NLM
Ho PL, Medina-Armenteros Y, Dati LMM, Cajado-Carvalho D, Silva CS, Campos PF, Abreu PAE, Castro JT de, Tonolli PN, Fujimori M, Rosa RSM, Palameta S, Miller ME, Sakiara VA, Valadares F de L, Lauretti-Ferreira F, Holanda BPC, Macedo DG de, Comone P, Fogaça N de SS, Bimbo A, Moraes FCD, Andrade STQ de, Arns CW, Kallas EG, Akamatsu MA, Oliveira R das N, Ferreira HL, Durigon EL. Production and immune response against pandemic influenza candidate vaccines as preparedness against the circulating H5N1 influenza viruses [Internet]. Vaccines. 2025 ; 13( 6): 21 .[citado 2026 fev. 08 ] Available from: https://doi.org/10.3390/vaccines13060620
Vancouver
Ho PL, Medina-Armenteros Y, Dati LMM, Cajado-Carvalho D, Silva CS, Campos PF, Abreu PAE, Castro JT de, Tonolli PN, Fujimori M, Rosa RSM, Palameta S, Miller ME, Sakiara VA, Valadares F de L, Lauretti-Ferreira F, Holanda BPC, Macedo DG de, Comone P, Fogaça N de SS, Bimbo A, Moraes FCD, Andrade STQ de, Arns CW, Kallas EG, Akamatsu MA, Oliveira R das N, Ferreira HL, Durigon EL. Production and immune response against pandemic influenza candidate vaccines as preparedness against the circulating H5N1 influenza viruses [Internet]. Vaccines. 2025 ; 13( 6): 21 .[citado 2026 fev. 08 ] Available from: https://doi.org/10.3390/vaccines13060620
Artigo de periodico
Amino compound-synthesized gold nanoparticles for SARS-CoV-2 antigen delivery (2025)
Rego, Layane Souza ; Favaro, Marianna Teixeira de Pinho ; Jesus, Mônica Josiane Rodrigues de ; Andreata-Santos, Robert ; Janini, Luiz Mário Ramos ; Seckler, Marcelo Martins ; Azzoni, Adriano Rodrigues ; Ferreira, Luís Carlos de Souza
Source: Pharmaceutics. Unidades: EP, ICB
Subjects: MICROBIOLOGIA, NANOPARTÍCULAS, COVID-19, AMINOÁCIDOS, ANTÍGENOS DE VÍRUS, VACINAS, IMUNOGENICIDADE DA VACINA, EPITOPOS, PROTEÍNAS RECOMBINANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REGO, Layane Souza et al. Amino compound-synthesized gold nanoparticles for SARS-CoV-2 antigen delivery. Pharmaceutics, v. 17, p. 15 , 2025Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics17091211. Acesso em: 08 fev. 2026.
APA
Rego, L. S., Favaro, M. T. de P., Jesus, M. J. R. de, Andreata-Santos, R., Janini, L. M. R., Seckler, M. M., et al. (2025). Amino compound-synthesized gold nanoparticles for SARS-CoV-2 antigen delivery. Pharmaceutics, 17, 15 . doi:10.3390/pharmaceutics17091211
NLM
Rego LS, Favaro MT de P, Jesus MJR de, Andreata-Santos R, Janini LMR, Seckler MM, Azzoni AR, Ferreira LC de S. Amino compound-synthesized gold nanoparticles for SARS-CoV-2 antigen delivery [Internet]. Pharmaceutics. 2025 ; 17 15 .[citado 2026 fev. 08 ] Available from: https://doi.org/10.3390/pharmaceutics17091211
Vancouver
Rego LS, Favaro MT de P, Jesus MJR de, Andreata-Santos R, Janini LMR, Seckler MM, Azzoni AR, Ferreira LC de S. Amino compound-synthesized gold nanoparticles for SARS-CoV-2 antigen delivery [Internet]. Pharmaceutics. 2025 ; 17 15 .[citado 2026 fev. 08 ] Available from: https://doi.org/10.3390/pharmaceutics17091211
Artigo de periodico
Enhanced immunogenicity and protective efficacy in mice following a Zika DNA vaccine designed by modulation of membrane-anchoring regions and its association to adjuvants (2024)
Teixeira, Franciane Mouradian Emidio; Oliveira, Luana de Mendonca; Branco, Anna Claudia Calvielli Castelo; Alberca, Ricardo Wesley; Sousa, Emanuella Sarmento Alho de; Leite, Bruno Henrique de Sousa; Adan, Wenny Camilla dos Santos; Duarte, Alberto José da Silva ; Lins, Roberto Dias; Sato, Maria Notomi ; Viana, Isabelle Freire Tabosa
Source: Frontiers in immunology. Unidade: FM
Subjects: ZIKA VÍRUS, IMUNIZAÇÃO, DENGUE, VACINAÇÃO, IMUNOGENICIDADE DA VACINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TEIXEIRA, Franciane Mouradian Emidio et al. Enhanced immunogenicity and protective efficacy in mice following a Zika DNA vaccine designed by modulation of membrane-anchoring regions and its association to adjuvants. Frontiers in immunology, v. 15, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/59033. Acesso em: 08 fev. 2026.
APA
Teixeira, F. M. E., Oliveira, L. de M., Branco, A. C. C. C., Alberca, R. W., Sousa, E. S. A. de, Leite, B. H. de S., et al. (2024). Enhanced immunogenicity and protective efficacy in mice following a Zika DNA vaccine designed by modulation of membrane-anchoring regions and its association to adjuvants. Frontiers in immunology, 15. doi:10.3389/fimmu.2024.1307546
NLM
Teixeira FME, Oliveira L de M, Branco ACCC, Alberca RW, Sousa ESA de, Leite BH de S, Adan WC dos S, Duarte AJ da S, Lins RD, Sato MN, Viana IFT. Enhanced immunogenicity and protective efficacy in mice following a Zika DNA vaccine designed by modulation of membrane-anchoring regions and its association to adjuvants [Internet]. Frontiers in immunology. 2024 ; 15[citado 2026 fev. 08 ] Available from: https://observatorio.fm.usp.br/handle/OPI/59033
Vancouver
Teixeira FME, Oliveira L de M, Branco ACCC, Alberca RW, Sousa ESA de, Leite BH de S, Adan WC dos S, Duarte AJ da S, Lins RD, Sato MN, Viana IFT. Enhanced immunogenicity and protective efficacy in mice following a Zika DNA vaccine designed by modulation of membrane-anchoring regions and its association to adjuvants [Internet]. Frontiers in immunology. 2024 ; 15[citado 2026 fev. 08 ] Available from: https://observatorio.fm.usp.br/handle/OPI/59033
Tese (Doutorado)
Avaliação da imunogenicidade e proteção de uma vacina inativada contra a febre amarela em associação com o domínio de helicase da proteína não estrutural 3 (ns3) (2024)
Floriano, Vitor Gonçalves ; Fonseca, Benedito Antonio Lopes da (Orientador)
Unidade: FMRP
Subjects: FEBRE AMARELA, VACINAÇÃO, IMUNOGENICIDADE DA VACINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FLORIANO, Vitor Gonçalves. Avaliação da imunogenicidade e proteção de uma vacina inativada contra a febre amarela em associação com o domínio de helicase da proteína não estrutural 3 (ns3). 2024. Tese (Doutorado) – Universidade de São Paulo, Ribeirão Preto, 2024. Disponível em: https://www.teses.usp.br/teses/disponiveis/17/17138/tde-04042025-114759/. Acesso em: 08 fev. 2026.
APA
Floriano, V. G. (2024). Avaliação da imunogenicidade e proteção de uma vacina inativada contra a febre amarela em associação com o domínio de helicase da proteína não estrutural 3 (ns3) (Tese (Doutorado). Universidade de São Paulo, Ribeirão Preto. Recuperado de https://www.teses.usp.br/teses/disponiveis/17/17138/tde-04042025-114759/
NLM
Floriano VG. Avaliação da imunogenicidade e proteção de uma vacina inativada contra a febre amarela em associação com o domínio de helicase da proteína não estrutural 3 (ns3) [Internet]. 2024 ;[citado 2026 fev. 08 ] Available from: https://www.teses.usp.br/teses/disponiveis/17/17138/tde-04042025-114759/
Vancouver
Floriano VG. Avaliação da imunogenicidade e proteção de uma vacina inativada contra a febre amarela em associação com o domínio de helicase da proteína não estrutural 3 (ns3) [Internet]. 2024 ;[citado 2026 fev. 08 ] Available from: https://www.teses.usp.br/teses/disponiveis/17/17138/tde-04042025-114759/
Artigo de periodico
Salivary assessment of the immune/inflammatory responses and oxidative stress in older adults vaccinated with CoronaVac or ChadOx-1 (2024)
Vieira, Jeniffer; Oliveira, Thiago Vinícius Vieira de; Queiroz, Lorrayne Rithielle Rocha; Camargo, Camila Tussato Soares ; Nardy, Ariane ; Monteiro, Fernanda Rodrigues ; Amaral, Jonatas Bussador do ; Paixão, Vitória ; Vaisberg, Mauro Walter ; Amirato, Gislene Rocha ; Santos, Carlos André Freitas dos ; Oliveira, Danielle Bruna Leal de ; Aguiar, Andressa Simões ; Alvares-Saraiva, Anuska Marcelino ; Heller, Débora ; Mantoanelli, Patricia Gabriela Viana ; Siqueira, Michelle Foigel; Nali, Luiz Henrique da Silva ; Bachi, André Luis Lacerda ; Durigon, Edison Luiz
Source: BMC Geriatrics. Unidade: ICB
Subjects: MICROBIOLOGIA, VACINAS VIRAIS, COVID-19, SALIVA, IDOSOS, CITOCINAS, IMUNOGLOBULINAS, IMUNOGENICIDADE DA VACINA, INFLAMAÇÃO, AGENTES ANTIMICROBIANOS, PEPTÍDEOS, ESTRESSE OXIDATIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIEIRA, Jeniffer et al. Salivary assessment of the immune/inflammatory responses and oxidative stress in older adults vaccinated with CoronaVac or ChadOx-1. BMC Geriatrics, v. 24, n. 1, p. 17 , 2024Tradução . . Disponível em: https://doi.org/10.1186/s12877-024-05357-8. Acesso em: 08 fev. 2026.
APA
Vieira, J., Oliveira, T. V. V. de, Queiroz, L. R. R., Camargo, C. T. S., Nardy, A., Monteiro, F. R., et al. (2024). Salivary assessment of the immune/inflammatory responses and oxidative stress in older adults vaccinated with CoronaVac or ChadOx-1. BMC Geriatrics, 24( 1), 17 . doi:10.1186/s12877-024-05357-8
NLM
Vieira J, Oliveira TVV de, Queiroz LRR, Camargo CTS, Nardy A, Monteiro FR, Amaral JB do, Paixão V, Vaisberg MW, Amirato GR, Santos CAF dos, Oliveira DBL de, Aguiar AS, Alvares-Saraiva AM, Heller D, Mantoanelli PGV, Siqueira MF, Nali LH da S, Bachi ALL, Durigon EL. Salivary assessment of the immune/inflammatory responses and oxidative stress in older adults vaccinated with CoronaVac or ChadOx-1 [Internet]. BMC Geriatrics. 2024 ; 24( 1): 17 .[citado 2026 fev. 08 ] Available from: https://doi.org/10.1186/s12877-024-05357-8
Vancouver
Vieira J, Oliveira TVV de, Queiroz LRR, Camargo CTS, Nardy A, Monteiro FR, Amaral JB do, Paixão V, Vaisberg MW, Amirato GR, Santos CAF dos, Oliveira DBL de, Aguiar AS, Alvares-Saraiva AM, Heller D, Mantoanelli PGV, Siqueira MF, Nali LH da S, Bachi ALL, Durigon EL. Salivary assessment of the immune/inflammatory responses and oxidative stress in older adults vaccinated with CoronaVac or ChadOx-1 [Internet]. BMC Geriatrics. 2024 ; 24( 1): 17 .[citado 2026 fev. 08 ] Available from: https://doi.org/10.1186/s12877-024-05357-8
Artigo de periodico
Immunogenicity of COVID-19 adsorbed inactivated vaccine (CoronaVac) and additional doses of mRNA BNT162b2 vaccine in immunocompromised adults compared with immunocompetent persons (2024)
Ibrahim, Karim Yaqub; Moreira, Raquel Megale; Santos, Carolina Ferreira dos; Strabelli, Tania Mara Varejao; Belizario, Juliana de Cassia; Pinto, Maria Isabel de Moraes; Marinho, Ana Karolina Barreto Berselli; Pereira, Juliana Marquezi; Mello, Liliane Saraiva de; Sartori, Ana Marli Christovam
Source: Revista do instituto de medicina tropical de São Paulo. Unidade: FM
Subjects: COVID-19, VACINAS, IMUNOGENICIDADE DA VACINA, HOSPEDEIRO IMUNOCOMPROMETIDO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
IBRAHIM, Karim Yaqub et al. Immunogenicity of COVID-19 adsorbed inactivated vaccine (CoronaVac) and additional doses of mRNA BNT162b2 vaccine in immunocompromised adults compared with immunocompetent persons. Revista do instituto de medicina tropical de São Paulo, v. 66, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/76944. Acesso em: 08 fev. 2026.
APA
Ibrahim, K. Y., Moreira, R. M., Santos, C. F. dos, Strabelli, T. M. V., Belizario, J. de C., Pinto, M. I. de M., et al. (2024). Immunogenicity of COVID-19 adsorbed inactivated vaccine (CoronaVac) and additional doses of mRNA BNT162b2 vaccine in immunocompromised adults compared with immunocompetent persons. Revista do instituto de medicina tropical de São Paulo, 66. doi:10.1590/S1678-9946202466024
NLM
Ibrahim KY, Moreira RM, Santos CF dos, Strabelli TMV, Belizario J de C, Pinto MI de M, Marinho AKBB, Pereira JM, Mello LS de, Sartori AMC. Immunogenicity of COVID-19 adsorbed inactivated vaccine (CoronaVac) and additional doses of mRNA BNT162b2 vaccine in immunocompromised adults compared with immunocompetent persons [Internet]. Revista do instituto de medicina tropical de São Paulo. 2024 ; 66[citado 2026 fev. 08 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76944
Vancouver
Ibrahim KY, Moreira RM, Santos CF dos, Strabelli TMV, Belizario J de C, Pinto MI de M, Marinho AKBB, Pereira JM, Mello LS de, Sartori AMC. Immunogenicity of COVID-19 adsorbed inactivated vaccine (CoronaVac) and additional doses of mRNA BNT162b2 vaccine in immunocompromised adults compared with immunocompetent persons [Internet]. Revista do instituto de medicina tropical de São Paulo. 2024 ; 66[citado 2026 fev. 08 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76944
Artigo de periodico
Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein (2024)
Silva, Mariângela de Oliveira ; Castro-Amarante, Maria Fernanda ; Carvalho, Alexia Adrianne Venceslau Brito ; Almeida, Bianca da Silva; Daher, Isabela Pazotti ; Souza-Silva, Guilherme Antonio de ; Yamamoto, Marcio Massao ; Koike, Gabriela ; Souza, Edmarcia Elisa de ; Wrenger, Carsten ; Ferreira, Luis Carlos de Souza ; Boscardin, Silvia Beatriz
Source: Vaccines. Unidades: ICB, FM
Subjects: PARASITOLOGIA, MICROBIOLOGIA, PROTEÍNAS RECOMBINANTES, PROTEÍNAS SANGUÍNEAS, ANTICORPOS, IMUNOGENICIDADE DA VACINA, IMUNOGENÉTICA, IMUNOGLOBULINAS, COVID-19, VACINAS VIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Mariângela de Oliveira et al. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein. Vaccines, v. 12, n. 4, p. 14 , 2024Tradução . . Disponível em: https://doi.org/10.3390/vaccines12040356. Acesso em: 08 fev. 2026.
APA
Silva, M. de O., Castro-Amarante, M. F., Carvalho, A. A. V. B., Almeida, B. da S., Daher, I. P., Souza-Silva, G. A. de, et al. (2024). Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein. Vaccines, 12( 4), 14 . doi:10.3390/vaccines12040356
NLM
Silva M de O, Castro-Amarante MF, Carvalho AAVB, Almeida B da S, Daher IP, Souza-Silva GA de, Yamamoto MM, Koike G, Souza EE de, Wrenger C, Ferreira LC de S, Boscardin SB. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein [Internet]. Vaccines. 2024 ; 12( 4): 14 .[citado 2026 fev. 08 ] Available from: https://doi.org/10.3390/vaccines12040356
Vancouver
Silva M de O, Castro-Amarante MF, Carvalho AAVB, Almeida B da S, Daher IP, Souza-Silva GA de, Yamamoto MM, Koike G, Souza EE de, Wrenger C, Ferreira LC de S, Boscardin SB. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein [Internet]. Vaccines. 2024 ; 12( 4): 14 .[citado 2026 fev. 08 ] Available from: https://doi.org/10.3390/vaccines12040356
Artigo de periodico
SpiN-Tec: a T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern (2024)
Hojo-Souza, Nathalia Satchiko ; Castro, Júlia T. de; Rivelli, Graziella Gomes ; Azevedo, Patrick Orestes de ; Oliveira, Emiliano Castro de ; Faustino, Lídia Paula ; Salazar, Natália; Bagno, Flávia Fonseca ; Carvalho, Alex F.; Rattis, Bruna Amanda da Cruz ; Lourenço, Karine Lima ; Gomes, Isabela P.; Assis, Bruna Rodrigues Dias; Piccin, Mariela Pires Cabral ; Fonseca, Flavio Guimarães da ; Souza, Renan Pedra de ; Goulart, Gisele Assis Castro ; Santiago, Helton da Costa ; Gazzinelli, Ricardo Tostes ; Silva, João Santana da ; Durigon, Edison Luiz
Source: Vaccine. Unidades: FMRP, ICB
Subjects: MICROBIOLOGIA, CAMUNDONGOS, HAMSTERS, PROTEÍNAS RECOMBINANTES, COVID-19, VACINAS VIRAIS, IMUNOGENICIDADE DA VACINA, IMUNIDADE, ADJUVANTES IMUNOLÓGICOS, ANTICORPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOJO-SOUZA, Nathalia Satchiko et al. SpiN-Tec: a T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern. Vaccine, v. 42, n. 26, p. 16 , 2024Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2024.126394. Acesso em: 08 fev. 2026.
APA
Hojo-Souza, N. S., Castro, J. T. de, Rivelli, G. G., Azevedo, P. O. de, Oliveira, E. C. de, Faustino, L. P., et al. (2024). SpiN-Tec: a T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern. Vaccine, 42( 26), 16 . doi:10.1016/j.vaccine.2024.126394
NLM
Hojo-Souza NS, Castro JT de, Rivelli GG, Azevedo PO de, Oliveira EC de, Faustino LP, Salazar N, Bagno FF, Carvalho AF, Rattis BA da C, Lourenço KL, Gomes IP, Assis BRD, Piccin MPC, Fonseca FG da, Souza RP de, Goulart GAC, Santiago H da C, Gazzinelli RT, Silva JS da, Durigon EL. SpiN-Tec: a T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern [Internet]. Vaccine. 2024 ; 42( 26): 16 .[citado 2026 fev. 08 ] Available from: https://doi.org/10.1016/j.vaccine.2024.126394
Vancouver
Hojo-Souza NS, Castro JT de, Rivelli GG, Azevedo PO de, Oliveira EC de, Faustino LP, Salazar N, Bagno FF, Carvalho AF, Rattis BA da C, Lourenço KL, Gomes IP, Assis BRD, Piccin MPC, Fonseca FG da, Souza RP de, Goulart GAC, Santiago H da C, Gazzinelli RT, Silva JS da, Durigon EL. SpiN-Tec: a T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern [Internet]. Vaccine. 2024 ; 42( 26): 16 .[citado 2026 fev. 08 ] Available from: https://doi.org/10.1016/j.vaccine.2024.126394
Artigo de periodico
Safety, efficacy, and immunogenicity of therapeutic vaccines for patients with high-grade cervical intraepithelial neoplasia (CIN 2/3) associated with human papillomavirus: a systematic review (2024)
Gonçalves, Caroline Amélia; Silva, Gabriela Pereira da; Silveira, Renata Cristina de Campos Pereira ; Mayer, Paulo César Morales; Zilly, Adriana; Lopes Júnior, Luís Carlos
Source: Cancers. Unidade: EERP
Subjects: HPV, IMUNOGENICIDADE DA VACINA, NEOPLASIAS, VACINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONÇALVES, Caroline Amélia et al. Safety, efficacy, and immunogenicity of therapeutic vaccines for patients with high-grade cervical intraepithelial neoplasia (CIN 2/3) associated with human papillomavirus: a systematic review. Cancers, v. 16, n. 3, p. 1-21, 2024Tradução . . Disponível em: https://doi.org/10.3390/cancers16030672. Acesso em: 08 fev. 2026.
APA
Gonçalves, C. A., Silva, G. P. da, Silveira, R. C. de C. P., Mayer, P. C. M., Zilly, A., & Lopes Júnior, L. C. (2024). Safety, efficacy, and immunogenicity of therapeutic vaccines for patients with high-grade cervical intraepithelial neoplasia (CIN 2/3) associated with human papillomavirus: a systematic review. Cancers, 16( 3), 1-21. doi:10.3390/cancers16030672
NLM
Gonçalves CA, Silva GP da, Silveira RC de CP, Mayer PCM, Zilly A, Lopes Júnior LC. Safety, efficacy, and immunogenicity of therapeutic vaccines for patients with high-grade cervical intraepithelial neoplasia (CIN 2/3) associated with human papillomavirus: a systematic review [Internet]. Cancers. 2024 ; 16( 3): 1-21.[citado 2026 fev. 08 ] Available from: https://doi.org/10.3390/cancers16030672
Vancouver
Gonçalves CA, Silva GP da, Silveira RC de CP, Mayer PCM, Zilly A, Lopes Júnior LC. Safety, efficacy, and immunogenicity of therapeutic vaccines for patients with high-grade cervical intraepithelial neoplasia (CIN 2/3) associated with human papillomavirus: a systematic review [Internet]. Cancers. 2024 ; 16( 3): 1-21.[citado 2026 fev. 08 ] Available from: https://doi.org/10.3390/cancers16030672
Artigo de periodico
A Structural In silico analysis of the immunogenicity of L-Asparaginase from Penicillium cerradense (2024)
Andrade, Kellen Cruvinel Rodrigues; Mello, Mauricio Homem de ; Motta, Julia Almeida; Borges, Marina Guimarães ; Abreu, Joel Antonio Cordeiro de ; Souza, Paula Monteiro ; Pessoa Junior, Adalberto ; Pappas Junior, Georgios Joannis ; Magalhães, Pérola de Oliveira
Source: International Journal of Molecular Sciences. Unidade: FCF
Subjects: IMUNOGENICIDADE DA VACINA, LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, Kellen Cruvinel Rodrigues et al. A Structural In silico analysis of the immunogenicity of L-Asparaginase from Penicillium cerradense. International Journal of Molecular Sciences, v. 25, p. 1-19 art. 4788, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/ijms25094788. Acesso em: 08 fev. 2026.
APA
Andrade, K. C. R., Mello, M. H. de, Motta, J. A., Borges, M. G., Abreu, J. A. C. de, Souza, P. M., et al. (2024). A Structural In silico analysis of the immunogenicity of L-Asparaginase from Penicillium cerradense. International Journal of Molecular Sciences, 25, 1-19 art. 4788. doi:10.3390/ijms25094788
NLM
Andrade KCR, Mello MH de, Motta JA, Borges MG, Abreu JAC de, Souza PM, Pessoa Junior A, Pappas Junior GJ, Magalhães P de O. A Structural In silico analysis of the immunogenicity of L-Asparaginase from Penicillium cerradense [Internet]. International Journal of Molecular Sciences. 2024 ; 25 1-19 art. 4788.[citado 2026 fev. 08 ] Available from: https://dx.doi.org/10.3390/ijms25094788
Vancouver
Andrade KCR, Mello MH de, Motta JA, Borges MG, Abreu JAC de, Souza PM, Pessoa Junior A, Pappas Junior GJ, Magalhães P de O. A Structural In silico analysis of the immunogenicity of L-Asparaginase from Penicillium cerradense [Internet]. International Journal of Molecular Sciences. 2024 ; 25 1-19 art. 4788.[citado 2026 fev. 08 ] Available from: https://dx.doi.org/10.3390/ijms25094788
Artigo de periodico
Safety and immunogenicity of a ChAd155-vectored respiratory syncytial virus vaccine in infants 6–7 months of age: a phase 1/2 randomized trial (2024)
Sáez-Llorens, Xavier; Norero, Ximena; Mussi-Pinhata, Marisa Márcia ; Luciani, Kathia; de la Cueva, Ignacio Salamanca; Díez-Domingo, Javier; Lopez-Medina, Eduardo; Epalza, Cristina; Brzostek, Jerzy; Szymański, Henryk; Boucher, François D.; Cetin, Benhur S.; De Leon, Tirza; Dinleyici, Ener Cagri; Gabriel, Miguel Ángel Marín; Ince, Tolga; Macias-Parra, Mercedes; Langley, Joanne M.; Martinón-Torres, Federico; Rämet, Mika; Kuchar, Ernest; Pinto, Jorge; Puthanakit, Thanyawee; Baquero-Artigao, Fernando; Gattinara, Guido Castelli; Arribas, Jose Manuel Merino; Amador, Jose Tomas Ramos; Szenborn, Leszek; Tapiero, Bruce; Anderson, Evan J.; Campbell, James D.; Faust, Saul N.; Nikic, Vanja; Zhou, Yingjun; Pu, Wenji; Friel, Damien; Dieussaert, Ilse; Lopez, Antonio Gonzalez; McPhee, Roderick; Stoszek, Sonia K.; Vanhoutte, Nicolas

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration

Área de concentração

Sigla do Departamento/Programa de Pós Graduação

Departamento/Programa de Pós Graduação